Rocket Pharmaceuticals, Inc.(RCKT)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
RCKT has no upcoming report date in the calendar yet. It last reported on Aug 10, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.0%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 3 misses.
In plain words: it beat expectations 5 times, but the stock still fell 2 of those 5 times.
- Aug '26Missed▼ -3.8%
- Feb '26Beat▲ +10.6%
- Nov '25Beat▼ -1.9%
- Aug '25Missed▲ +2.3%
- Feb '25Beat▲ +0.5%
- Nov '24Beat▲ +1.2%
- Aug '24Missed▲ +0.9%
- Nov '23Beat▼ -4.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did RCKT fall after beating earnings?
4 of RCKT's last 8 reactions went against the EPS result. What stands out in each:
RCKT beat EPS estimates in 5 quarters, and the stock still closed lower the next day 2 times.
- Nov 6, 2025EPS beat +13.5%stock -1.9% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 7, 2023EPS beat +3.8%stock -4.4% next day
- It had risen 8.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.3% higher, but sellers took over and it closed -4.4%.
Rose despite an EPS miss (2 of 3)
- Aug 6, 2025EPS missed -11.3%stock +2.3% next day
- It had already fallen 5.6% in the 20 trading sessions before the report, so weak results may have been expected.
- Aug 5, 2024EPS missed -2.8%stock +0.9% next day
- It had already fallen 19.1% in the final week before the report, so weak results may have been expected.
- It opened 4.5% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was RCKT's earnings move already priced in?
RCKT's move in the month before each of its last 9 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 9 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does RCKT hold its opening gap after earnings?
RCKT's opening move after each report and where it closed that day.
In 5 reports RCKT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 5 times (80%), and fully reversed 2 times.
- May 7, 2026ReversedOpened +2.7%, closed -1.1%
- Feb 26, 2026HeldOpened +1.3%, closed +10.6%
- Feb 27, 2025FadedOpened +1.6%, closed +0.5%
- Aug 5, 2024FadedOpened +4.5%, closed +0.9%
- Nov 7, 2023ReversedOpened +2.3%, closed -4.4%
What the history says
- It fell after 2 of its 5 EPS beats (40%): beating estimates has not been enough on its own.
RCKT earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | After close | $0.35 | -$0.38 | -208.6% | -3.85% | -8.24% |
| May 7, 2026 | After close | -$0.45 | -$0.42 | sources differ | -1.09% | -0.82% |
| Feb 26, 2026 | After close | -$0.42 | -$0.38 | +9.5% | +10.60% | +5.96% |
| Nov 6, 2025 | After close | -$0.52 | -$0.45 | +13.5% | -1.86% | +0.93% |
| Aug 6, 2025 | After close | -$0.53 | -$0.59 | -11.3% | +2.32% | -3.31% |
| May 8, 2025 | After close | -$0.58 | -$0.56 | +3.4% | — | — |
| Feb 27, 2025 | After close | -$0.72 | -$0.62 | +13.9% | +0.53% | -7.87% |
| Nov 7, 2024 | After close | -$0.75 | -$0.71 | +5.3% | +1.16% | -7.07% |
| Aug 5, 2024 | After close | -$0.72 | -$0.74 | -2.8% | +0.85% | -4.16% |
| May 5, 2024 | After close | -$0.67 | -$0.66 | +1.5% | — | — |
| Feb 25, 2024 | After close | -$0.77 | -$0.64 | +16.9% | — | — |
| Nov 7, 2023 | After close | -$0.78 | -$0.75 | +3.8% | -4.40% | -9.38% |
RCKT Earnings FAQ
Answers computed from Rocket Pharmaceuticals, Inc.'s reported history
RCKT has no upcoming report date in the calendar yet. It last reported on Aug 10, 2026; companies usually report every three months.
Over the last 11 quarters with a usable EPS surprise, RCKT beat the consensus estimate 8 times (73%), missed 3 and landed in line 0. 1 quarter where our data sources disagree on beat versus miss are shown but not counted.
Across its last 9 quarters with a measured reaction, RCKT moved an average of ±3.0% in the first session after reporting. It closed higher 56% of the time; the largest gain was 10.6% and the largest drop -4.4%.
RCKT fell in the first session after 2 of its last 5 EPS beats (40%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 9 quarters with price data, RCKT moved an average of +0.9% in the 20 trading sessions before reporting and was higher in 44% of them. After a run-up of 3% or more (3 quarters), it fell the next day 33% of the time, averaging +2.5%. After a drop of 3% or more (4 quarters), it rose the next day 75% of the time, averaging +0.5%. This describes past reports; it is not a forecast.
In 5 reports RCKT opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 5 times (80%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · RCKT: 12 reported quarters, latest Aug 10, 2026. Information only, not investment advice.
Looking for more on RCKT?
Price charts, forecast, fundamentals and risk pages for RCKT are not on Tickzen yet. You can run a full stock analysis now.
Run the RCKT Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun